SCA
BIIB icon

Sage Capital Advisors’s Biogen BIIB Stock Holding History

Sage Capital Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-6,779
Closed -$1.58M – 105
2019
Q3 		$1.58M Buy
6,779
+109
+2% +$25.4K 1.19% 31
2019
Q2 		$1.55M Buy
+6,670
New +$1.54M 1.07% 33

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Sage Capital Advisors's BIIB Position: Q4 2019 in Review

Sage Capital Advisors sold out of Biogen (BIIB) in Q4 2019, closing a stake of 6,779 shares — an estimated $1.58M sold.

Sage Capital Advisors first reported a position in BIIB in Q2 2019 and held it in 2 quarters. The position peaked at $1.58M in Q3 2019. 1,103 funds tracked by Wall St. Rank hold BIIB as of Q4 2019.

  • Sage Capital Advisors reported no remaining Biogen position as of Q4 2019 after selling out during the quarter.
  • Sage Capital Advisors sold 6,779 Biogen shares in Q4 2019, an estimated $1.58M.
  • Sage Capital Advisors first reported a position in Biogen in Q2 2019 and held it in 2 quarters.
  • Sage Capital Advisors's Biogen position peaked at $1.58M in Q3 2019.
  • 1,103 funds tracked by Wall St. Rank held Biogen as of Q4 2019.

Based on Sage Capital Advisors's 13F filing for Q4 2019, filed 16 Jan 2020.